Loading... Please wait...

Allogene Therapeutics, Inc. (ALLO) Analyst Forecast

Currency in USD Disclaimer
$2.08 -$0.08 (-3.7%)
$2.08
$2.2
$2.08
$6.05
  • Consensus Rating

    Buy

    Based on 4 Analyst Ratings

  • Consensus Price Target

    $29.00

    1294.23% Upside

Recent Analyst Forecasts and Stock Ratings


Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside on Report Date Details
05/16/2024 H.C. Wainwright Debjit Chattopadhyay $9.00 $2.98   202.01%
05/14/2024 B.Riley Financial Kalpit Patel $7.00 $2.90   141.38%
06/13/2022 Robert W. Baird Jack Allen $11.00 $9.74   12.94%
01/02/2022 Guggenheim Michael Schmidt $35.00 $15.29   128.91%
12/02/2021 Canaccord Genuity John Newman $55.00 $17.62   212.15%
10/07/2021 Roth Capital Anthony Butler $35.00 $13.13   166.57%
10/07/2021 Bank of America Securities Jason Gerberry $32.00 $13.13   143.72%
10/07/2021 Oppenheimer Mark Breidenbach $40.00 $13.13   204.65%
10/07/2021 Jefferies Biren Amin $30.00 $13.13   128.48%
09/22/2021 Raymond James Dane Leone $36.00 $27.64   30.25%

Allogene Therapeutics, Inc. Frequently Asked Questions

  • Q. What analysts cover Allogene Therapeutics, Inc.?

    A. Allogene Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, B.Riley Financial, Robert W. Baird, Guggenheim, Canaccord Genuity, Roth Capital in the past 90 days.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.